Table 6.
Number of participants classified as plasmatic Aβ+ or plasmatic Aβ− based on the plasma soluble Aβ42/Aβ40 ratio, using a threshold of 0.0465, as determined by decision tree, and according to their amyloid status determined by CSF or PET analysis.
All Individuals | CSF/PET Aβ+ | CSF/PET Aβ− |
---|---|---|
Plasmatic Aβ+ | 64 | 32 |
Plasmatic Aβ− | 10 | 45 |